Australia's most trusted
source of pharma news
Thursday, 05 March 2026
Posted 5 March 2026 PM
A new study is underway to support the development of Inoviq’s population-based screening test for ovarian cancer.
Led by the University of Queensland (UQ), the EARLY study aims to collect blood samples from 1,500 women across Queensland to evaluate the impact of shipment and storage on the stability of ovarian cancer biomarkers.

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.